caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1003800939

Elvin MendezMD

Allergy/ ImmunologyPort Charlotte, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 100244
Hospital
REFERRAL NETWORK

Where Elvin Mendez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
2270
PUNTA GORDA HMA LLC1942
PORT CHARLOTTE HMA LLC1544
HERNANDEZ, HECTOR1526
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Tampa, FL
57171
HERNANDEZ, HECTOR1953
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
1950
PUNTA GORDA HMA LLC1334
FAWCETT MEMORIAL HOSPITAL, INC.1227
PORT CHARLOTTE HMA LLC1237
Gulf Coast Dermatopathology Laboratory, Inc.
Clinical Laboratory · Tampa, FL
1116
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
54
Unique beneficiaries
—
Total services
60
Distinct HCPCS
4
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 196 Allergy/ Immunology providers in FL — bottom quintile (cohort median 5,512).
PRESCRIBING · PART D · 2024
Total Rx claims
126
Beneficiaries
—
Total drug cost
$138K
Distinct drugs
6
Brand share
58.7%
Top prescribed drugs
Omalizumab48 claims
Levocetirizine Dihydrochloride26 claims
Azelastine Hcl13 claims
Azelastine/Fluticasone13 claims
Fluticasone/Vilanterol13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$17
Payment records
1
By payment type
Education$17